Trials / Completed
CompletedNCT00002252
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of Sandostatin (octreotide) compared to placebo in controlling diarrhea which is a manifestation or complication of documented HIV infection and which is refractory (does not respond) to all known treatment classes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Octreotide |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002252. Inclusion in this directory is not an endorsement.